{"ticker": {"uuid": "f10d86b7-9f9e-4997-975e-dff8ee5ad1d7", "symbol": "DARE", "name": "Dare Bioscience Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Dar\u00e9 Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025", "summary": "Dar\u00e9 Bioscience will host a conference call and live webcast on Monday, March 31, 2025, at 4:30 p.m. Eastern Time. The call will cover the company's financial results for the year ended December 31, 2024, and provide a general company update. Interested parties can access the cal", "url": "https://news.futunn.com/th/post/54644484/dare-bioscience-to-host-full-year-2024-financial-results-and", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T15:42:11", "published_display": "14 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Dare Bioscience, Inc. Reports Material Event", "summary": "Dare Bioscience, Inc. (DARE) has filed an 8-K report announcing the furnishing of a new corporate presentation dated July 13, 2026. This presentation is being used in meetings with securities market participants and will be available in the Investors section of the company's webs", "url": "https://www.stocktitan.net/sec-filings/DARE/8-k-dare-bioscience-inc-reports-material-event-43022da97773.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:42:10", "published_display": "13 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Dare Bioscience Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggNBVV95cUxPVkpXUThEY0E5WDJTWWpBQW9hUXN3OUhLTHluWlFxQW10Vkg0Y0ZMWEloR3dUeGRIU095azYxM3FsTk5yV0F1NmY3WWlaNlNxNDVJdU1fSFc1SjhDSHhHRnVMcVpaMkk4ZUlKLTNEN3VCX2JRcmwyV1ZPNjVLRkJ2V09pb29jdzAwOU80SlpOai1hVXI5aG5PUWZPSmVESlYtbGtPTkFMWFY2djFIMEwzMUhSSE1GSFp1dE45LUF5cjRaS3pIUFA3MjAyMjZiZDdhWGItRFQ0U1Nab3hEY1FqQV9PZDNNek0weVlsbjJuTTlrRkJaOFRwaGJ1bzJqSTJNNGJVN3BWdGdkLTdWV0Y3S1dFMkhjbWhVLURBcFNSdW90dTBPOVJFQU9kMmNxNWV1SGZVR1BkUHRNZGN4UEhwWGhqUEZjQmZha1pBNHZJdVB0eWhBQVVXRFdtcGFHTXRMQzRKeV9OVm9RbVhFOWxFM2ZqbWRtNnhhcHhIWi15YVpyQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-12T03:06:48+00:00", "published_display": "12 Jul 2026 03:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event", "summary": "Sabrina Martucci Johnson, CEO of Dar\u00e9 Bioscience (NASDAQ: DARE), will participate in a Virtual Investor Closing Bell event on July 14, 2026, at 4:00 PM ET. She will provide a corporate overview, highlighting the recent launch of FloraSync LF5\u2122, the company's commercial strategy, ", "url": "https://www.globenewswire.com/news-release/2026/07/09/3324804/0/en/dar%C3%A9-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event.html", "source_name": "GlobeNewswire", "published_at": "2026-07-10T02:10:24", "published_display": "10 Jul 2026 02:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience CEO to discuss FloraSync launch, Q&A July 14", "summary": "Dar\u00e9 Bioscience (NASDAQ: DARE) CEO Sabrina Martucci Johnson will participate in a Virtual Investor Closing Bell event on July 14, 2026, at 4:00 PM ET. She will provide a corporate overview, highlight the recent launch of FloraSync LF5\u2122, discuss the company's growth strategy, and ", "url": "https://www.stocktitan.net/news/DARE/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-4e21gl3nyjgw.html", "source_name": "Stock Titan", "published_at": "2026-07-09T12:14:06", "published_display": "09 Jul 2026 12:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Dare Bioscience, Inc. \u2013 NASDAQ:DARE", "summary": "This article focuses on the \"Price to sales forward\" metric for Dare Bioscience, Inc. (NASDAQ: DARE). It appears to be a financial data page from TradingView, providing an overview of the company's financial performance. The content is primarily a navigation and site structure, w", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T04:10:13", "published_display": "08 Jul 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Dare Bioscience Inc (DARE). Based on various technical indicators and moving averages, the consensus for DARE is currently a \"Sell.\" Key support is identified at $1.969 and resistance at $2.199, with the stoc", "url": "https://intellectia.ai/en/stock/DARE/technical", "source_name": "Intellectia AI", "published_at": "2026-07-07T12:41:35", "published_display": "07 Jul 2026 12:41", "sentiment": "negative", "sentiment_pct": 30, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience launches prescription-free vaginal probiotic capsule for microbiome support", "summary": "Dar\u00e9 Bioscience has launched Flora Sync LF5, a prescription-free vaginal probiotic capsule containing Limosilactobacillus fermentum LF5, available through its direct-to-consumer platform. Clinical trials showed comparable efficacy to miconazole in treating vulvovaginal candidiasi", "url": "https://www.contemporaryobgyn.net/view/dare-bioscience-flora-sync-lf5-vaginal-probiotic-launch", "source_name": "Contemporary OB/GYN", "published_at": "2026-07-06T18:11:54", "published_display": "06 Jul 2026 18:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Dare Bioscience, Inc. \u2013 NASDAQ:DARE", "summary": "The article focuses on the \"Price to earnings forward\" metric for Dare Bioscience, Inc. (NASDAQ: DARE) as presented on TradingView. It appears to be a financial data page rather than a detailed analytical article, showing the company's financial overview within the health technol", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T00:40:05", "published_display": "05 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Dare Bioscience, Inc. \u2013 NASDAQ:DARE", "summary": "The article focuses on the enterprise value to EBIT forward for Dare Bioscience, Inc., traded on the Nasdaq Stock Market under the ticker DARE. It appears to be a financial data point provided by TradingView, possibly within a larger financial analysis platform. The content prima", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T20:39:17", "published_display": "04 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) director receives 23,696 RSUs in lieu of cash pay", "summary": "Dare Bioscience director Susan L. Kelley was granted 23,696 restricted stock units (RSUs) as compensation for her board service, replacing cash pay. Each RSU represents one share of common stock and will vest on January 4, 2027. Following this transaction, Kelley's direct holding", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-6ce1367e7ab5.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:10:33", "published_display": "03 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) grants 38,862 RSUs to board director", "summary": "Dare Bioscience (DARE) director William H. Rastetter has been granted 38,862 restricted stock units (RSUs) as compensation for his service on the board and its committees. These RSUs, granted at $0.00 per share, will vest on January 4, 2027, and directly increase his holdings to ", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-63b008ef6632.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) director receives 26,540 RSUs in lieu of cash fees", "summary": "Dare Bioscience director Robin Joan Steele was granted 26,540 restricted stock units (RSUs) as compensation for her board service, replacing cash fees. These RSUs, which represent a contingent right to one common stock share each, will vest on January 4, 2027. Following this tran", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-98b50587a703.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) director awarded 30,805 RSUs as board compensation", "summary": "Dare Bioscience director Gregory W. Matz received 30,805 restricted stock units (RSUs) as compensation for his service on the company's board and committees. These RSUs convert into one share each upon vesting on January 4, 2027, and after this grant, Matz directly holds 30,847 s", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-582051b5ffc9.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Jessica Grossman gets 26,066 RSUs at Dare Bioscience (NASDAQ: DARE)", "summary": "Jessica D. Grossman, a director at Dare Bioscience (NASDAQ: DARE), has been granted 26,066 Restricted Stock Units (RSUs) as non-cash compensation for her board service. These RSUs, valued at $0.00 per share for the grant, will fully vest on January 4, 2027, and each unit represen", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-c3c95d9fabff.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience\u2019s vaginal probiotic is now for sale online", "summary": "Dar\u00e9 Bioscience (NASDAQ: DARE) has launched Flora Sync LF5\u2122, a non-hormonal vaginal probiotic capsule, directly to consumers through its DARE Health Hub, marking its first consumer product revenue stream. The product, priced at $49 per box, is formulated with a vagina-specific pr", "url": "https://www.stocktitan.net/news/DARE/dare-bioscience-announces-flora-sync-lf5tm-is-now-available-through-l557iqjue24i.html", "source_name": "Stock Titan", "published_at": "2026-07-01T13:09:54", "published_display": "01 Jul 2026 13:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Announces Flora Sync LF5\u2122 Is Now Available Through Its Direct-to-Consumer Platform", "summary": "Dar\u00e9 Bioscience has launched Flora Sync LF5\u2122, a vaginal probiotic capsule, making it available directly to consumers without a prescription. This launch signifies the company's transition into a revenue-generating entity, with Flora Sync LF5\u2122 being its first consumer product. The", "url": "https://www.globenewswire.com/news-release/2026/07/01/3320620/0/en/Dar%C3%A9-Bioscience-Announces-Flora-Sync-LF5-Is-Now-Available-Through-Its-Direct-to-Consumer-Platform.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T08:55:00", "published_display": "01 Jul 2026 08:55", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience, Inc. Actuals & Estimates (NASDAQ:DARE)", "summary": "This article provides an overview of Dare Bioscience, Inc. (NASDAQ:DARE) stock, covering current price, market capitalization, volatility, and historical performance. It also includes analyst forecasts for future prices, details on recent actual earnings and revenue compared to e", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:40", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Dare Bioscience, Inc. (DARE) stock, including analyst price targets, historical performance, and key financial metrics. It highlights that three analysts have a 1-year price forecast, with a current DARE price of $2.09, and discusses the compa", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T20:40:40", "published_display": "25 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5\u2122 in Virtual Investor \u201cWhat This Means\u201d Segment", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/dar-bioscience-highlights-revenue-opportunity-130500938.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T13:05:00+00:00", "published_display": "25 Jun 2026 13:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Highlights Revenue Opportunity as CEO", "summary": "Dar\u00e9 Bioscience announced its participation in a Virtual Investor \"What This Means\" segment, where CEO Sabrina Martucci Johnson discussed the upcoming commercial launch of Flora Sync LF5\u2122. This vaginal probiotic capsule marks the company's first consumer health product, positioni", "url": "https://www.globenewswire.com/news-release/2026/06/25/3317617/30757/en/dar%C3%A9-bioscience-highlights-revenue-opportunity-as-ceo-discusses-upcoming-launch-of-flora-sync-lf5-in-virtual-investor-what-this-means-segment.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T13:10:54", "published_display": "25 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience says Flora Sync LF5 could bring first product revenue", "summary": "Dar\u00e9 Bioscience (NASDAQ: DARE) highlighted the upcoming June 2026 commercial launch of Flora Sync LF5\u2122, a vagina-specific probiotic capsule intended to restore microbiome balance and support vaginal comfort. This product is Dar\u00e9's first consumer health product and is anticipated ", "url": "https://www.stocktitan.net/news/DARE/dare-bioscience-highlights-revenue-opportunity-as-ceo-discusses-jlzhxblnzoja.html", "source_name": "Stock Titan", "published_at": "2026-06-25T13:10:54", "published_display": "25 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience, Inc. (DARE) Presents at BIO International Convention 2026 - Slideshow (NASDAQ:DARE) 2026-06-23", "summary": "Dar\u00e9 Bioscience, Inc. (DARE) has published a slide deck in connection with its presentation at the BIO International Convention 2026. This article, provided by SA Transcripts, highlights the availability of these materials for investors.", "url": "https://seekingalpha.com/article/4916860-dare-bioscience-inc-dare-presents-at-bio-international-convention-2026-slideshow?source=generic_rss", "source_name": "Seeking Alpha", "published_at": "2026-06-23T05:10:09", "published_display": "23 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Dare Bioscience Inc For: 22 June By Investing.com", "summary": "This article announces the filing of a Form 8K by Dare Bioscience Inc. on June 22. It mentions DARE's current stock performance and is primarily a notice about the regulatory filing rather than an in-depth analysis.", "url": "https://ca.investing.com/news/stock-market-news/form-8k-dare-bioscience-inc-for-22-june-93CH-4700969", "source_name": "Investing.com Canada", "published_at": "2026-06-22T13:41:50", "published_display": "22 Jun 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) unveils June 22, 2026 corporate investor presentation", "summary": "Dare Bioscience (DARE) has released a new corporate investor presentation dated June 22, 2026, filed as Exhibit 99.1 under a Regulation FD disclosure. The presentation will be used for meetings with securities market participants and will be available on the company's website in ", "url": "https://www.stocktitan.net/sec-filings/DARE/8-k-dare-bioscience-inc-reports-material-event-7bff4567f48f.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:41:50", "published_display": "22 Jun 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience Inc (DARE) Institutional Confidence", "summary": "The institutional confidence score for Dare Bioscience Inc (DARE) is 3.00, placing it 94th in the Pharmaceuticals industry. Institutional shareholding has increased by 23.58% quarter-over-quarter, now standing at 8.57% of outstanding shares. James Simons is the largest institutio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dare/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T17:40:17", "published_display": "18 Jun 2026 17:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience Inc (DARE) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Dare Bioscience Inc (DARE), listing major individual and institutional holders and their percentage of ownership. It also provides a breakdown of shareholder types, including corporations, investment advisors, and hedge funds. Fur", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dare/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T15:11:16", "published_display": "18 Jun 2026 15:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026", "summary": "Dar\u00e9 Bioscience, a health biotech company focused on women's health, announced that its President and CEO, Sabrina Martucci Johnson, will participate in multiple speaking engagements and deliver a corporate presentation at the BIO International Convention 2026. The convention off", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314270/0/en/dar%C3%A9-bioscience-to-showcase-leadership-in-women-s-health-innovation-at-bio-international-convention-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T13:11:16", "published_display": "18 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience CEO joins BIO 2026 panels on women\u2019s health", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZnRFZ0Z6di1YdGgxd1NQdzhfRjl0aUJaTnVWQUxrbVBiVzVFRGZ6WUZ1N09jajRXYmRUWm9kV0VjczN6VXlaQmJBdG4yQ0V3bUlEX3pHdjZDQnZReXRhVTd0bkZ1MGpaMDlWLXZ3RFlXcF8yYVVhdm5VWGZPc1M1WjJNQk5ZWnhwbzdGNXJObTZnSHNEN2VZUWVrOHVqYlNWSFk4YVE5Zlp2cU83dU5ybUl5VkV5M2lUeEsyTTE4aw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Announces the Upcoming Launch of Flora Sync LF5\u2122 Vaginal Probiotic Capsules", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dar-bioscience-announces-upcoming-launch-120000810.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T12:00:00+00:00", "published_display": "04 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dar-bioscience-receives-nih-funding-120000536.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T12:00:00+00:00", "published_display": "26 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Dare Bioscience outlines liquidity and revenue plans in Q1 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPUWppVDlETDdhb2JVQ0xudGxHZFAwMHFKZk9TMmp0SVJiTm9jOWFDSzFFT0s1RVIwODBMZWZuTkphVzZoWVNSWngyWnVuelp2akdvMzBVZWxLVklfRll5ZmVJc3NrempWTTFYUldab010clR6U2dERGlTUzNvYzdHLUcxckJiUXRCdHBIbUlwN1U1Y0NzbEluTW41anpWaUcwTkN3STFnRHZtUG5VeWRvT2VWU2d4WGp3d3FEc255RFdFZGoxYWl3ZGtRR3JRUnJDOEQ2UDloZHFDZGRhd201TVh0cw?oc=5", "source_name": "Investing.com UK", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dar-bioscience-initiates-phase-2-120000251.html", "source_name": "GlobeNewswire", "published_at": "2026-05-18T12:00:00+00:00", "published_display": "18 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience begins phase 2 trial for HPV treatment By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMkFqS2ZXMW9hZzltNzRiXzkxR3RjM2dRTWpkQ1VmekZFU05BTk5MdmdFZkNXb2dBeC1URkhPMElMT21UUXV4X2VRS1A4elFlRzNLV0E4R0tmN05aOElKMkMtOXo3NEtSSmJxNHd6M1drbjlKMzhwclFIN05ZMTZlMmRBRWREQnNMNUhjNE0tZVU2S0VrY0gzM0JhTnZHaTE5Q1Z3QnpCSFdDUHA1aGwtTnpyRE5YZw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Dare Bioscience Inc (DARE) Q1 2026 Earnings Call Highlights: Strategic Milestones and Financial ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dare-bioscience-inc-dare-q1-050313046.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:03:13+00:00", "published_display": "15 May 2026 05:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxNS2dyNEhRWmtTckpTakhXNGVxOFc5OXZoQ2JWN09jZFJweHZFR1c0X2lBU3dGRGNaQWlyQl9uTTVoVXBUbVBRcmR2NE5ib21vOFpOXzBaemhLTWFOWDdEUEZSOUdEdUJZNGEzY1RSNFJidzVQc0lYSndhS1BIVHExV21Tb0xVLW5EbWlhaFZNcEJ2X09YbE81VGV4YTl6REpMWko2Z1B4cllKMUpZZVdKRWJsXzJ6S3VzMnlaMWI5ZmlvU3JIYzRoSmhXZHZ3eURheHR2ZXBEYTZEcG5IR1lGQi1pdXhHWHNEckVWVGJaUF9GRDdxR0JYbDR1MXAyMGs?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Dare Bioscience completes closing of Regulation A offering of preferred stock and warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOYkJYZlE2TFUtX2FFTmY0eGExRG9RdmJCTHBUZC04VkZMV3dpZFFYbG94eUlZckpISElUaGMzeDc1WFVQMkNxelZ0NmhmaF9NUUVCWkEyd2h5RFFlWG83bjloNVcyTkZYUE8zdDB3SWkyYlhiNG45WEprcEdNcmlHb0tNQlUzc285TlBndEVISDcwel9kVXdZV3dSUUFnMGlMMlhtY0dGNGE0clZ2eUJlNmJrbWJaU1cya0p2aHpDM09OTGtTb2NhX1hGSGFOM2VmSTZwUmhTSTgwcDdqYVN3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Surges As Dar\u00e9 Bioscience Unveils Women\u2019s Health Catalysts\u200b", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9EUFlXcllJUzBLdEdpaWQ3Uy11cWFmVHhnZTlFOUo5U0ZldGJJcnVldnNMTUNZemZOV1p2OER6cHF1N1BTb3c4ekVPSGNSeFNqRlhwcmZ0eHFDSmlrb2drWTVPSGVKUmlZOWZyVHlmMzVYcjlwMHBjTzB3?oc=5", "source_name": "StocksToTrade", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Bioscience Jumps As DARE to PLAY Launch and Pipeline Catalysts Draw Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5ENmZpZXNuUGlfQW9RT3FNckZ2R1BaTzEyVk5Ick1tckpzYlU3ZFhjcm12eHlERnE3Mkc1VFZKWU9wX3Nnbld3V1ZDTS0wd0t2Wm1hT3RYazF2b2x0S293TXQ2NkdRbzdSVlNXTVVqUWR1WDhYaW1Rd3Rn?oc=5", "source_name": "StocksToTrade", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSkhmcE1XOTQ4NkJONTg5NXU5eUtoak14Uzc5dGJubTJxUnlVT0xfMTdtWGdsRU0tSER4am43Y0pBR3hraDNmT2p5Z3dyMlRsamFkU0c1aE5XelNmTGhUZk96eHZCM01tRjNOc3QxYm96enR5X2pka29VNzVpWkdIV2FtdHdmR3pVQmhjLU14Z2ltV1lDajZ2RGN2dVpJdw?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9fZmo4VmxsRDhrNnRfaEtyT3kxUlpmYkFWWDJWSFJtcWkwT1VBZVNDb0hoVk1EaFFfLUlHWFlIdW9NUm5hUzhCRjdUcEpTWUFuUU9V?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T02:38:37+00:00", "published_display": "25 Apr 2025 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Stock Price and Chart \u2014 NASDAQ:DARE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9JOFJXN1JJVEpiVU5OLWxaYXU5LVBJSU8wNjhYRDNBRWo3Z3cxLXVUQTFPdkVkQTZuM2dGTHNfeEFudm9pVTl1YnNzTC1wcW1yR2VXSE5seFQ2bTBE?oc=5", "source_name": "TradingView", "published_at": "2017-07-21T21:40:01+00:00", "published_display": "21 Jul 2017 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Dar\u00e9 Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025", "summary": "Dar\u00e9 Bioscience will host a conference call and live webcast on Monday, March 31, 2025, at 4:30 p.m. Eastern Time. The call will cover the company's financial results for the year ended December 31, 2024, and provide a general company update. Interested parties can access the cal", "url": "https://news.futunn.com/th/post/54644484/dare-bioscience-to-host-full-year-2024-financial-results-and", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T15:42:11", "published_display": "14 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] Dare Bioscience, Inc. Reports Material Event", "summary": "Dare Bioscience, Inc. (DARE) has filed an 8-K report announcing the furnishing of a new corporate presentation dated July 13, 2026. This presentation is being used in meetings with securities market participants and will be available in the Investors section of the company's webs", "url": "https://www.stocktitan.net/sec-filings/DARE/8-k-dare-bioscience-inc-reports-material-event-43022da97773.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:42:10", "published_display": "13 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience Company Profile & Introduction", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moomoo", "published_at": "2026-07-12T03:06:48+00:00", "published_display": "12 Jul 2026 03:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event", "summary": "Sabrina Martucci Johnson, CEO of Dar\u00e9 Bioscience (NASDAQ: DARE), will participate in a Virtual Investor Closing Bell event on July 14, 2026, at 4:00 PM ET. She will provide a corporate overview, highlighting the recent launch of FloraSync LF5\u2122, the company's commercial strategy, ", "url": "https://www.globenewswire.com/news-release/2026/07/09/3324804/0/en/dar%C3%A9-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-virtual-investor-closing-bell-event.html", "source_name": "GlobeNewswire", "published_at": "2026-07-10T02:10:24", "published_display": "10 Jul 2026 02:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience CEO to discuss FloraSync launch, Q&A July 14", "summary": "Dar\u00e9 Bioscience (NASDAQ: DARE) CEO Sabrina Martucci Johnson will participate in a Virtual Investor Closing Bell event on July 14, 2026, at 4:00 PM ET. She will provide a corporate overview, highlight the recent launch of FloraSync LF5\u2122, discuss the company's growth strategy, and ", "url": "https://www.stocktitan.net/news/DARE/dare-bioscience-ceo-sabrina-martucci-johnson-to-participate-in-4e21gl3nyjgw.html", "source_name": "Stock Titan", "published_at": "2026-07-09T12:14:06", "published_display": "09 Jul 2026 12:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Dare Bioscience, Inc. \u2013 NASDAQ:DARE", "summary": "This article focuses on the \"Price to sales forward\" metric for Dare Bioscience, Inc. (NASDAQ: DARE). It appears to be a financial data page from TradingView, providing an overview of the company's financial performance. The content is primarily a navigation and site structure, w", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T04:10:13", "published_display": "08 Jul 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis and stock price forecast for Dare Bioscience Inc (DARE). Based on various technical indicators and moving averages, the consensus for DARE is currently a \"Sell.\" Key support is identified at $1.969 and resistance at $2.199, with the stoc", "url": "https://intellectia.ai/en/stock/DARE/technical", "source_name": "Intellectia AI", "published_at": "2026-07-07T12:41:35", "published_display": "07 Jul 2026 12:41", "sentiment": "negative", "sentiment_pct": 30, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience launches prescription-free vaginal probiotic capsule for microbiome support", "summary": "Dar\u00e9 Bioscience has launched Flora Sync LF5, a prescription-free vaginal probiotic capsule containing Limosilactobacillus fermentum LF5, available through its direct-to-consumer platform. Clinical trials showed comparable efficacy to miconazole in treating vulvovaginal candidiasi", "url": "https://www.contemporaryobgyn.net/view/dare-bioscience-flora-sync-lf5-vaginal-probiotic-launch", "source_name": "Contemporary OB/GYN", "published_at": "2026-07-06T18:11:54", "published_display": "06 Jul 2026 18:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Dare Bioscience, Inc. \u2013 NASDAQ:DARE", "summary": "The article focuses on the \"Price to earnings forward\" metric for Dare Bioscience, Inc. (NASDAQ: DARE) as presented on TradingView. It appears to be a financial data page rather than a detailed analytical article, showing the company's financial overview within the health technol", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T00:40:05", "published_display": "05 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Dare Bioscience, Inc. \u2013 NASDAQ:DARE", "summary": "The article focuses on the enterprise value to EBIT forward for Dare Bioscience, Inc., traded on the Nasdaq Stock Market under the ticker DARE. It appears to be a financial data point provided by TradingView, possibly within a larger financial analysis platform. The content prima", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T20:39:17", "published_display": "04 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) director receives 23,696 RSUs in lieu of cash pay", "summary": "Dare Bioscience director Susan L. Kelley was granted 23,696 restricted stock units (RSUs) as compensation for her board service, replacing cash pay. Each RSU represents one share of common stock and will vest on January 4, 2027. Following this transaction, Kelley's direct holding", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-6ce1367e7ab5.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:10:33", "published_display": "03 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) grants 38,862 RSUs to board director", "summary": "Dare Bioscience (DARE) director William H. Rastetter has been granted 38,862 restricted stock units (RSUs) as compensation for his service on the board and its committees. These RSUs, granted at $0.00 per share, will vest on January 4, 2027, and directly increase his holdings to ", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-63b008ef6632.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) director receives 26,540 RSUs in lieu of cash fees", "summary": "Dare Bioscience director Robin Joan Steele was granted 26,540 restricted stock units (RSUs) as compensation for her board service, replacing cash fees. These RSUs, which represent a contingent right to one common stock share each, will vest on January 4, 2027. Following this tran", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-98b50587a703.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) director awarded 30,805 RSUs as board compensation", "summary": "Dare Bioscience director Gregory W. Matz received 30,805 restricted stock units (RSUs) as compensation for his service on the company's board and committees. These RSUs convert into one share each upon vesting on January 4, 2027, and after this grant, Matz directly holds 30,847 s", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-582051b5ffc9.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Jessica Grossman gets 26,066 RSUs at Dare Bioscience (NASDAQ: DARE)", "summary": "Jessica D. Grossman, a director at Dare Bioscience (NASDAQ: DARE), has been granted 26,066 Restricted Stock Units (RSUs) as non-cash compensation for her board service. These RSUs, valued at $0.00 per share for the grant, will fully vest on January 4, 2027, and each unit represen", "url": "https://www.stocktitan.net/sec-filings/DARE/form-4-dare-bioscience-inc-insider-trading-activity-c3c95d9fabff.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:12", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience\u2019s vaginal probiotic is now for sale online", "summary": "Dar\u00e9 Bioscience (NASDAQ: DARE) has launched Flora Sync LF5\u2122, a non-hormonal vaginal probiotic capsule, directly to consumers through its DARE Health Hub, marking its first consumer product revenue stream. The product, priced at $49 per box, is formulated with a vagina-specific pr", "url": "https://www.stocktitan.net/news/DARE/dare-bioscience-announces-flora-sync-lf5tm-is-now-available-through-l557iqjue24i.html", "source_name": "Stock Titan", "published_at": "2026-07-01T13:09:54", "published_display": "01 Jul 2026 13:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Announces Flora Sync LF5\u2122 Is Now Available Through Its Direct-to-Consumer Platform", "summary": "Dar\u00e9 Bioscience has launched Flora Sync LF5\u2122, a vaginal probiotic capsule, making it available directly to consumers without a prescription. This launch signifies the company's transition into a revenue-generating entity, with Flora Sync LF5\u2122 being its first consumer product. The", "url": "https://www.globenewswire.com/news-release/2026/07/01/3320620/0/en/Dar%C3%A9-Bioscience-Announces-Flora-Sync-LF5-Is-Now-Available-Through-Its-Direct-to-Consumer-Platform.html", "source_name": "GlobeNewswire", "published_at": "2026-07-01T08:55:00", "published_display": "01 Jul 2026 08:55", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience, Inc. Actuals & Estimates (NASDAQ:DARE)", "summary": "This article provides an overview of Dare Bioscience, Inc. (NASDAQ:DARE) stock, covering current price, market capitalization, volatility, and historical performance. It also includes analyst forecasts for future prices, details on recent actual earnings and revenue compared to e", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:40", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Dare Bioscience, Inc. (DARE) stock, including analyst price targets, historical performance, and key financial metrics. It highlights that three analysts have a 1-year price forecast, with a current DARE price of $2.09, and discusses the compa", "url": "https://www.tradingview.com/symbols/NASDAQ-DARE/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T20:40:40", "published_display": "25 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5\u2122 in Virtual Investor \u201cWhat This Means\u201d Segment", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/dar-bioscience-highlights-revenue-opportunity-130500938.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T13:05:00+00:00", "published_display": "25 Jun 2026 13:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Highlights Revenue Opportunity as CEO", "summary": "Dar\u00e9 Bioscience announced its participation in a Virtual Investor \"What This Means\" segment, where CEO Sabrina Martucci Johnson discussed the upcoming commercial launch of Flora Sync LF5\u2122. This vaginal probiotic capsule marks the company's first consumer health product, positioni", "url": "https://www.globenewswire.com/news-release/2026/06/25/3317617/30757/en/dar%C3%A9-bioscience-highlights-revenue-opportunity-as-ceo-discusses-upcoming-launch-of-flora-sync-lf5-in-virtual-investor-what-this-means-segment.html", "source_name": "GlobeNewswire", "published_at": "2026-06-25T13:10:54", "published_display": "25 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience says Flora Sync LF5 could bring first product revenue", "summary": "Dar\u00e9 Bioscience (NASDAQ: DARE) highlighted the upcoming June 2026 commercial launch of Flora Sync LF5\u2122, a vagina-specific probiotic capsule intended to restore microbiome balance and support vaginal comfort. This product is Dar\u00e9's first consumer health product and is anticipated ", "url": "https://www.stocktitan.net/news/DARE/dare-bioscience-highlights-revenue-opportunity-as-ceo-discusses-jlzhxblnzoja.html", "source_name": "Stock Titan", "published_at": "2026-06-25T13:10:54", "published_display": "25 Jun 2026 13:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience, Inc. (DARE) Presents at BIO International Convention 2026 - Slideshow (NASDAQ:DARE) 2026-06-23", "summary": "Dar\u00e9 Bioscience, Inc. (DARE) has published a slide deck in connection with its presentation at the BIO International Convention 2026. This article, provided by SA Transcripts, highlights the availability of these materials for investors.", "url": "https://seekingalpha.com/article/4916860-dare-bioscience-inc-dare-presents-at-bio-international-convention-2026-slideshow?source=generic_rss", "source_name": "Seeking Alpha", "published_at": "2026-06-23T05:10:09", "published_display": "23 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 8K Dare Bioscience Inc For: 22 June By Investing.com", "summary": "This article announces the filing of a Form 8K by Dare Bioscience Inc. on June 22. It mentions DARE's current stock performance and is primarily a notice about the regulatory filing rather than an in-depth analysis.", "url": "https://ca.investing.com/news/stock-market-news/form-8k-dare-bioscience-inc-for-22-june-93CH-4700969", "source_name": "Investing.com Canada", "published_at": "2026-06-22T13:41:50", "published_display": "22 Jun 2026 13:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) unveils June 22, 2026 corporate investor presentation", "summary": "Dare Bioscience (DARE) has released a new corporate investor presentation dated June 22, 2026, filed as Exhibit 99.1 under a Regulation FD disclosure. The presentation will be used for meetings with securities market participants and will be available on the company's website in ", "url": "https://www.stocktitan.net/sec-filings/DARE/8-k-dare-bioscience-inc-reports-material-event-7bff4567f48f.html", "source_name": "Stock Titan", "published_at": "2026-06-22T12:41:50", "published_display": "22 Jun 2026 12:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience Inc (DARE) Institutional Confidence", "summary": "The institutional confidence score for Dare Bioscience Inc (DARE) is 3.00, placing it 94th in the Pharmaceuticals industry. Institutional shareholding has increased by 23.58% quarter-over-quarter, now standing at 8.57% of outstanding shares. James Simons is the largest institutio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dare/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T17:40:17", "published_display": "18 Jun 2026 17:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience Inc (DARE) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Dare Bioscience Inc (DARE), listing major individual and institutional holders and their percentage of ownership. It also provides a breakdown of shareholder types, including corporations, investment advisors, and hedge funds. Fur", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-dare/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T15:11:16", "published_display": "18 Jun 2026 15:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026", "summary": "Dar\u00e9 Bioscience, a health biotech company focused on women's health, announced that its President and CEO, Sabrina Martucci Johnson, will participate in multiple speaking engagements and deliver a corporate presentation at the BIO International Convention 2026. The convention off", "url": "https://www.globenewswire.com/news-release/2026/06/18/3314270/0/en/dar%C3%A9-bioscience-to-showcase-leadership-in-women-s-health-innovation-at-bio-international-convention-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T13:11:16", "published_display": "18 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience CEO joins BIO 2026 panels on women\u2019s health", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNZnRFZ0Z6di1YdGgxd1NQdzhfRjl0aUJaTnVWQUxrbVBiVzVFRGZ6WUZ1N09jajRXYmRUWm9kV0VjczN6VXlaQmJBdG4yQ0V3bUlEX3pHdjZDQnZReXRhVTd0bkZ1MGpaMDlWLXZ3RFlXcF8yYVVhdm5VWGZPc1M1WjJNQk5ZWnhwbzdGNXJObTZnSHNEN2VZUWVrOHVqYlNWSFk4YVE5Zlp2cU83dU5ybUl5VkV5M2lUeEsyTTE4aw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Announces the Upcoming Launch of Flora Sync LF5\u2122 Vaginal Probiotic Capsules", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dar-bioscience-announces-upcoming-launch-120000810.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T12:00:00+00:00", "published_display": "04 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dar-bioscience-receives-nih-funding-120000536.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T12:00:00+00:00", "published_display": "26 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Dare Bioscience outlines liquidity and revenue plans in Q1 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPUWppVDlETDdhb2JVQ0xudGxHZFAwMHFKZk9TMmp0SVJiTm9jOWFDSzFFT0s1RVIwODBMZWZuTkphVzZoWVNSWngyWnVuelp2akdvMzBVZWxLVklfRll5ZmVJc3NrempWTTFYUldab010clR6U2dERGlTUzNvYzdHLUcxckJiUXRCdHBIbUlwN1U1Y0NzbEluTW41anpWaUcwTkN3STFnRHZtUG5VeWRvT2VWU2d4WGp3d3FEc255RFdFZGoxYWl3ZGtRR3JRUnJDOEQ2UDloZHFDZGRhd201TVh0cw?oc=5", "source_name": "Investing.com UK", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dar-bioscience-initiates-phase-2-120000251.html", "source_name": "GlobeNewswire", "published_at": "2026-05-18T12:00:00+00:00", "published_display": "18 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience begins phase 2 trial for HPV treatment By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMkFqS2ZXMW9hZzltNzRiXzkxR3RjM2dRTWpkQ1VmekZFU05BTk5MdmdFZkNXb2dBeC1URkhPMElMT21UUXV4X2VRS1A4elFlRzNLV0E4R0tmN05aOElKMkMtOXo3NEtSSmJxNHd6M1drbjlKMzhwclFIN05ZMTZlMmRBRWREQnNMNUhjNE0tZVU2S0VrY0gzM0JhTnZHaTE5Q1Z3QnpCSFdDUHA1aGwtTnpyRE5YZw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience Inc (DARE) Q1 2026 Earnings Call Highlights: Strategic Milestones and Financial ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/dare-bioscience-inc-dare-q1-050313046.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T05:03:13+00:00", "published_display": "15 May 2026 05:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxNS2dyNEhRWmtTckpTakhXNGVxOFc5OXZoQ2JWN09jZFJweHZFR1c0X2lBU3dGRGNaQWlyQl9uTTVoVXBUbVBRcmR2NE5ib21vOFpOXzBaemhLTWFOWDdEUEZSOUdEdUJZNGEzY1RSNFJidzVQc0lYSndhS1BIVHExV21Tb0xVLW5EbWlhaFZNcEJ2X09YbE81VGV4YTl6REpMWko2Z1B4cllKMUpZZVdKRWJsXzJ6S3VzMnlaMWI5ZmlvU3JIYzRoSmhXZHZ3eURheHR2ZXBEYTZEcG5IR1lGQi1pdXhHWHNEckVWVGJaUF9GRDdxR0JYbDR1MXAyMGs?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience completes closing of Regulation A offering of preferred stock and warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOYkJYZlE2TFUtX2FFTmY0eGExRG9RdmJCTHBUZC04VkZMV3dpZFFYbG94eUlZckpISElUaGMzeDc1WFVQMkNxelZ0NmhmaF9NUUVCWkEyd2h5RFFlWG83bjloNVcyTkZYUE8zdDB3SWkyYlhiNG45WEprcEdNcmlHb0tNQlUzc285TlBndEVISDcwel9kVXdZV3dSUUFnMGlMMlhtY0dGNGE0clZ2eUJlNmJrbWJaU1cya0p2aHpDM09OTGtTb2NhX1hGSGFOM2VmSTZwUmhTSTgwcDdqYVN3?oc=5", "source_name": "Investing.com", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Surges As Dar\u00e9 Bioscience Unveils Women\u2019s Health Catalysts\u200b", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9EUFlXcllJUzBLdEdpaWQ3Uy11cWFmVHhnZTlFOUo5U0ZldGJJcnVldnNMTUNZemZOV1p2OER6cHF1N1BTb3c4ekVPSGNSeFNqRlhwcmZ0eHFDSmlrb2drWTVPSGVKUmlZOWZyVHlmMzVYcjlwMHBjTzB3?oc=5", "source_name": "StocksToTrade", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Bioscience Jumps As DARE to PLAY Launch and Pipeline Catalysts Draw Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE5ENmZpZXNuUGlfQW9RT3FNckZ2R1BaTzEyVk5Ick1tckpzYlU3ZFhjcm12eHlERnE3Mkc1VFZKWU9wX3Nnbld3V1ZDTS0wd0t2Wm1hT3RYazF2b2x0S293TXQ2NkdRbzdSVlNXTVVqUWR1WDhYaW1Rd3Rn?oc=5", "source_name": "StocksToTrade", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSkhmcE1XOTQ4NkJONTg5NXU5eUtoak14Uzc5dGJubTJxUnlVT0xfMTdtWGdsRU0tSER4am43Y0pBR3hraDNmT2p5Z3dyMlRsamFkU0c1aE5XelNmTGhUZk96eHZCM01tRjNOc3QxYm96enR5X2pka29VNzVpWkdIV2FtdHdmR3pVQmhjLU14Z2ltV1lDajZ2RGN2dVpJdw?oc=5", "source_name": "Market source", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dar\u00e9 Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dare Bioscience (DARE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9fZmo4VmxsRDhrNnRfaEtyT3kxUlpmYkFWWDJWSFJtcWkwT1VBZVNDb0hoVk1EaFFfLUlHWFlIdW9NUm5hUzhCRjdUcEpTWUFuUU9V?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T02:38:37+00:00", "published_display": "25 Apr 2025 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DARE Stock Price and Chart \u2014 NASDAQ:DARE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9JOFJXN1JJVEpiVU5OLWxaYXU5LVBJSU8wNjhYRDNBRWo3Z3cxLXVUQTFPdkVkQTZuM2dGTHNfeEFudm9pVTl1YnNzTC1wcW1yR2VXSE5seFQ2bTBE?oc=5", "source_name": "TradingView", "published_at": "2017-07-21T21:40:01+00:00", "published_display": "21 Jul 2017 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 86, "total_relevant": 52, "sentiment_summary": {"positive": 10, "negative": 3, "neutral": 39, "score": 53, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 14.65, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 9.76, "count": 20}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.02, "latest_week": "2026-07-10", "one_week_move": -3.3, "four_week_move": 0.0, "twelve_week_move": -31.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.028759, "market_dynamics_buy_signal": false, "relative_strength": -14.500116, "fair_value_gap": -42.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 48.2611, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.3% over one week, +0.0% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 12}, {"label": "GlobeNewswire", "count": 9}, {"label": "TradingView", "count": 7}, {"label": "Market source", "count": 6}, {"label": "simplywall.st", "count": 3}, {"label": "TradingKey", "count": 2}, {"label": "StocksToTrade", "count": 2}, {"label": "StockStory", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 43}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 20}, {"label": "Balance sheet", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "43", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-3.3% over one week, +0.0% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Dar\u00e9 Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025"}], "updated_at": "2026-07-16T19:30:37.309153+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}